A paralyzed man has regained the ability to communicate with the world thanks to a revolutionary brain implant that converts his thoughts into text. The device, called BrainGate, was developed by a team of neuroscientists who implanted electrodes into the man's brain and connected them to a computer. The computer then decodes the signals from the brain and displays them on a screen.

Neuralink, the brain-implant company founded by visionary entrepreneur Elon Musk, has reached a significant milestone with the approval of its first-in-human clinical trial by the U.S. Food and Drug Administration (FDA). This breakthrough represents a crucial step forward for Neuralink, following previous challenges in obtaining regulatory clearance for its groundbreaking technology. With the FDA's green light, Neuralink is now one step closer to fulfilling its mission of utilizing brain implants to address a wide range of conditions and potentially unlock extraordinary capabilities such as web browsing and telepathy.